|
|
|
SPECTRA DENTA |
Home
> Product > SPECTRA DENTA |
|
|
|
|
|
|
|
| |
| Quality |
|
| In order to provide consistent laser interaction
on oral soft tissue, stable energy and peak power is critical
for dental laser to previde reliable and reproducible results
over time. With the built-in Digital Feedback System(DFS), Spectra
DENTA offers consistent peak power throughout the durantion
of every treatment |
|
 |
 |
 |
| |
The Spectra
DENTA advantage :
- Precise incision,
excision and vaporization
- Clinically proven sterile procedures
- Minimized risk of unwanted charring and thermal
necrosis
- Wide range of handpiece tips
- Quality patient care :
- Pain-free and bloodless
procedures
- Reduced need for anesthesia
and sutures
- Faster wound healing
|
|
 |
 |
 |
|
| Precision |
| The small spot size and minimal
absorption depth allows this CO2 laser to provide
an exceptional level of precision. With proper selection
of power and delivery mode, it is possible to remove
a single layer of cells during intraoral surgery.
the Spectra DENTA allows the user precise control
to achieve desired results |
| Sterilization |
| Spectra DENTA kill -organisms
on contact. Completely absorbed by water, the laser
heats the |
|
|
|
| surface of the tissue to temperatures that
eliminates bactericidal contamination and inflammation. The
outcome allows for highly effective sterilization of the surgical
field and minimizes post-operative infections. |
|
| Wound Healing |
|
| Because there is no direct contact, procedures
with the pain and hemirrhang-free Spectra DENTA seal off blood
vessels and nerve endings, resulting in faster would healing
widthout postoperative symptoms |
|
| Handpiece Tips |
|
| Spectra DANTA comes with a wide range of
on-the-fly swappable handpiece tips to allow physicians to dial
in the precise amount of thermal damage. |
|
| Safe & Easy to Use |
|
Spectra DENTA is simple and its easy to use
functions minimize the risk of charring and collateral thermal
damage, resulting in faster healing and grater patient satisfaction.
Air regulation and guide beam brightness controls allow for
even more convenience to the user
|
|
 |
 |
 |
| |
| Laser Type |
Surgical Carbon Dioxide
Laser |
| Wavelength |
10.6 &;m |
| Mode Structure |
True TEMoo Mode |
| Display |
Graphic LCD |
| Memory |
User programmable settings |
| Safety |
Internal safety shutter
& feedback system |
| Spot Size |
0.2mm |
| Delivery System |
Articulated Arm with 7
mirrors |
| Power Requirement |
12/6A, 110/220V, 50/60Hz,
Single Phase |
| Frequency |
Superpulse mode : 1Hz
- 180Hz
Char-Free mode : 1Hz - 700Hz |
| Optical Delivery |
Continus Wave(CW) mode
: 0.5-25W
Superpluse mode : 0.1 -7W
Char-Free(CF) mode : 0.1 -7W |
| Aiming Beam |
Green, 532nm, 1-3mW, Adjustable |
| Pulse Duration |
Superpulse mode : 1msec
-5msec
Char-Free mode : 4&;s -1000&;s |
| Frequency |
Superpulse mode : 1Hz
- 180Hz
Char-Free mode : 1Hz - 700Hz |
| Weight |
35kg |
| Dimensions |
840mm(H)×380mm(W)×960mm(L)
|
| Quality Standards |
FDA,CE
ISO 9001:2000, EN ISO 13485:2003 |
| |
|
|
|
 |
 |
 |
|
|
|
|
| Reference |
|
| 1. |
Cheung-Yeoul Park, Su-Gwan Kim, et al. Surface properties
of endosseous dental implants after Nd :YAG and CO2 laser
treatment at various energies. Journal of Oral and Maxillofacial
Surgery 2005;63:1522-1527. |
| 2. |
Stubinger S, Henke J, Donath K, Deppe H. Bone regeneration
after peri-implant care with the CO2 laser : a fluorescence
scopy study. Int J Oral Maxillofac Implants 2005
Mar-Apr;20(2):203-10. |
| 3. |
Deppe H, Greim H, Brill T, Wagenpfeil S. Titanium deposition
after peri-implant care with the carbon dioxide laser.
Int j Oral Maxillofac Implants 2002 Sep-Oct;17(5):707-14.
|
| 4. |
Kreisler M, Al Haj H, Gotz H, Duschner H, d'Hoedt B.
Effect of simulated CO2 and GaAIAs laser surface decontamination
on temperature changes in Ti-plasma sprayed dental implants.
Lasers Surg Med 2002;30(3):233-9. |
| 5. |
Kreisler M, Gotz H, Duschner H. Effect of Nd:YAG, Ho:YAG,
Er:YAG, CO2 , and GaAIAs laser irradiation on surface
properties of endosseous dental implants. Int J Oral Maxillofac
Implants 2002 Mar-Apr;17(2):202-11. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
